Insider trading

Period: 120 months Stock: ELV Share of holding: 50% or more × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

14 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

14 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

14 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

14 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
14 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
14 decisions over 120 months Remove this filter
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

14 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
5 Mar 2026
COLLIS STEVEN H Director
Bought
$869.52K 3,000 at 289.84
469%
First buy on file
19 Aug 2025
DeVore Susan D. Director
Bought
$374.58K 1,200 at 312.15
52.1%
First buy on file
4 Mar 2024
Haytaian Peter D EVP & Pres Carelon & CarelonRx
Sold on a plan 3×
$10.55M 21,095 at 500.18
52.8%
Sold half or more
10 Mar 2022
Haytaian Peter D EVP & Pres., DBG & IngenioRx
Sold, plan not stated 6×
$8.16M 17,703 at 460.71
59.3%
Sold half or more
3 Mar 2022
Penczek Ronald W CAO & Controller
Sold, plan not stated
$1.12M 2,423 at 463.68
56.0%
Sold half or more
7 Feb 2022
Penczek Ronald W CAO & Controller
Sold, plan not stated
$1.25M 2,763 at 453.48
57.9%
Sold half or more
22 Mar 2021
Haytaian Peter D EVP & President, Commercial
Sold, plan not stated 7×
$20.78M 59,500 at 349.20
72.5%
Sold half or more
4 Feb 2021
Bought
$503.25K 1,700 at 296.03
139%
First buy on file
26 Jul 2018
Samitt Craig E EVP & President, DBG
Sold, plan not stated
$4.82M 19,541 at 246.68
53.1%
Sold half or more
3 May 2018
GRIFFIN BRIAN T EVP & CEO, IngenioRx
Sold, plan not stated 2×
$13.33M 59,421 at 224.41
78.9%
Sold half or more
7 Mar 2018
Penczek Ronald W SVP, Chief Accounting Officer
Sold, plan not stated 2×
$455.92K 1,966 at 231.90
67.9%
Sold half or more
5 Mar 2018
Gallina John E EVP & Chief Financial Officer
Sold, plan not stated 3×
$5.65M 24,576 at 229.81
60.7%
Sold half or more
11 Jan 2018
Swedish Joseph Executive Chairman
Sold, plan not stated 3×
$15.92M 67,500 at 235.87
50.4%
Sold half or more
2 Mar 2017
ZIELINSKI THOMAS C EVP & General Counsel
Sold, plan not stated 2×
$3.81M 22,936 at 166.29
52.1%
Sold half or more
Showing 1–14 of 14.